BioNTech Earnings and Sales Top Wall Street Forecasts
barron's2022-05-09
BioNTech, the German biotech company, reported first-quarter earnings and sales that topped Wall Street expectations.
The company, which partnered with Pfizer to develop the first Covid-19 vaccine approved for use in the U.S., earned €14.24 a share in the quarter on revenue of €6.37 billion.
Analysts surveyed by FactSet were expecting earnings of €9.16 a share on revenue of €4.34 billion. A year earlier, the company earned €4.39 a share on sales of €2.05 billion.
American depositary receipts of BioNTech (ticker: BNTX) rose 1.93% to $138.80 in premarket trading Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
